Younger adults are more susceptible to asymptomatic rhinovirus infections, whereas older adults are more likely to experience respiratory symptoms.

Symptomatic improvement on therapy for myeloproliferative neoplasms (MPNs) is very much based on the individual. Data does show momelotinib not only improved spleen size and anemia but also improved ...